Retinoid chemistry: Synthesis and application for metabolic disease

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1821, Issue 1, 2012, Pages 3-9

  Curley Jr , Robert W ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Diabetes; Metabolic disease; Obesity; Retinoid; Structure activity relationship; Synthesis

Indexed keywords

ADIPOPHILIN; BINDING PROTEIN; CAROTENOID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; RETINOID; RETINOID X RECEPTOR;

ADIPOGENESIS; DIABETES MELLITUS; HORNER REACTION; HUMAN; INSULIN RESISTANCE; ISOMERIZATION; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

DIABETES MELLITUS; HUMANS; METABOLIC DISEASES; METABOLIC SYNDROME X; OBESITY; RETINOIDS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 83255192152     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2011.04.007     Document Type: Review

References (82)

1. E.V. McCollum, and M. Davis Necessity of certain lipins in the diet during growth J. Biol. Chem. 15 1913 167 175
2. E. Wald Carotenoids and the vitamin A cycle in vision Nature 143 1934 65
3. S.B. Wolbach, and P.R. Howe Tissue changes following deprivation of fat-soluble A vitamin J. Exp. Med. 42 1925 753 777
4. G.L. Peck, and J.J. DiGiovanna Synthetic retinoids in dermatology M.B. Sporn, A.B. Roberts, D.S. Goodman, The Retinoids: Biology, Chemistry, and Medicine 2nd ed. 1994 Raven Press New York 630 658
5. R.C. Moon, R.G. Mehta, and K.V.N. Rao Retinoids and cancer in experimental animals M.B. Sporn, A.B. Roberts, D.S. Goodman, The Retinoids: Biology, Chemistry, and Medicine 2nd ed. 1994 Raven Press New York 573 595
6. W.K. Hong, and L.M. Itri Retinoids and human cancer M.B. Sporn, A.B. Roberts, D.S. Goodman, The Retinoids: Biology, Chemistry, and Medicine 2nd ed. 1994 Raven Press New York 597 630
7. A. Maercker The Wittig reaction Org. React. 14 1965 270 490
8. R.W. Curley Jr., and H.F. DeLuca Ethyl 13,14-dihydro-13,14- methyleneretinoates: analogues of all-trans and 13-cis-retinoic acid J. Org. Chem. 49 1984 1944 1946
9. G. Pattenden, J.E. Way, and B.C.L. Weedon Carotenoids and related compounds. Part XXVI. Synthesis of methyl natural bixin J. Chem. Soc. C: Org. 1970 235 241
10. R.W. Curley Jr., and C.J. Ticoras A convenient synthesis of important retinoid synthon ethyl 3-formyl-2-butenoate Synth. Commun. 16 1986 627 631
11. R.W. Dugger, and C.H. Heathcock An efficient preparation of trans, trans-β-ionylideneacetaldehyde Synth. Commun. 10 1980 509 515
12. J.E. Safaryn, J. Chiarello, K.M. Chen, and M.M. Joullie A convenient synthesis of (±)-ascochlorin Tetrahedron 42 1986 2635 2642
13. M. Julia, and D. Arnould Use of sulfones in synthesis. III. Synthesis of vitamin A Bull. Soc. Chim. Fr. 1973 746 750
14. D. Koch, and W. Gartner Steric hindrance between chromophore substituents as the driving force of rhodopsin isomerization: 10-methyl-13-demethyl retinal containing rhodopsin Photochem. Photobiol. 65 1997 181 186
15. A. Stephens-Jarnagin, D.A. Miller, and H.F. DeLuca The growth supporting activity of a retinoidal benzoic acid derivative and 4,4-difluororetinoic acid Arch. Biochem. Biophys. 237 1985 11 16
16. M.I. Dawson, and P.D. Hobbs The synthetic chemistry of retinoids M.B. Sporn, A.B. Roberts, D.S. Goodman, The Retinoids: Biology, Chemistry, and Medicine 2nd ed. 1994 Raven Press New York 5 178
17. B. Dominguez, A. Alvarez, and A.R. de Lera Recent advances in the synthesis of retinoids Org. Prep. Int. 35 2003 239 306
18. A.R. Valla, D.L. Cartier, and R. Labia Chemistry of natural retinoids and carotenoids: challenges for the future Curr. Org. Synth. 1 2004 167 209
19. M.F. Boehm, L. Zhang, B.A. Badea, S.K. White, D.E. Mais, E. Berger, C.M. Suto, M.E. Goldman, and R.A. Heyman Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids J. Med. Chem. 37 1994 2930 2941
20. D.J. Mangelsdorf, K. Umesono, and R.M. Evans The retinoid receptors M.B. Sporn, A.B. Roberts, D.S. Goodman, The Retinoids: Biology, Chemistry, and Medicine 2nd ed. 1994 Raven Press New York 319 349
21. S. Nagpal, and R.A.S. Chandraratna Recent developments in receptor-selective retinoids Curr. Pharm. Des. 6 2000 919 931
22. P. Lefebvre Molecular basis for designing selective modulators of retinoic acid receptor transcriptional activities Curr. Drug Targets 1 2001 153 164
23. F.C. Zusi, M.V. Lorenzi, and V. Vivat-Hannah Selective retinoids and rexinoids in cancer therapy and chemoprevention Drug Discov. Today 7 2002 1165 1174
24. V. Vivat-Hannah, and F.C. Zusi Retinoids as therapeutic agents: today and tomorrow Mini-Rev. Med. Chem. 5 2005 755 760
25. A.R. de Lera, W. Bourguet, L. Altucci, and H. Gronemeyer Design of selective nuclear receptor modulators, RAR and RXR as a case study Nat. Rev. Drug Discovery 6 2007 811 820
26. M.I. Dawson, and J.A. Fontana The peptidomimetic, 1-adamantyl- substituted, and flex-het classes of retinoid-derived molecules: their structure-activity relationships and retinoid receptor-independent activities Mini-Rev. Med. Chem. 10 2010 455 491
27. R.C. Moon, H.J. Thompson, P.J. Becci, C.J. Grubb, R.J. Gander, D.L. Newton, J.M. Smith, S.L. Phillips, W.R. Henderson, L.T. Mullen, C.C. Brown, and M.B. Sporn N-(4-Hydroxyphenyl) retinamide, a new retinoid for prevention of breast cancer in the rat Cancer Res. 39 1979 1339 1346
28. F. Villaroya, R. Iglesias, and M. Giralt Retinoids and retinoid receptors in the control of energy balance: novel pharmacological strategies in obesity and diabetes Curr. Med. Chem. 11 2004 795 805
29. I. Safranova, C. Darimont, E.Z. Amri, P. Grimaldi, G. Ailhaud, U. Reichert, and B. Shroot Retinoids are positive effectors of adipose cell differentiation Mol. Cell. Endocrinol. 104 1994 201 211
30. J.-C. Xue, E.J. Schwarz, A. Chawla, and M.A. Lazar Distinct stages of adipogenesis revealed by retinoid inhibition of differentiation after induction of PPARγ Mol. Cell. Biol. 16 1996 1567 1575
31. A. Redonnet, C. Ferrand, C. Bairras, P. Higueret, C. Noel-Suberville, P. Cassand, and C. Atgie Synergic effect of vitamin A and high fat diet in adipose tissue development and nuclear receptor expression in young rats Br. J. Nutr. 100 2008 722 730
32. N. Shaw, M. Elholm, and N. Noy Retinoic acid is a high affinity selective ligand for the peroxisome proliferator-activated receptor β/δ J. Biol. Chem. 278 2003 41589 41592
33. D.C. Berry, and N. Noy All-trans-retinoic acid represses obesity and insulin resistance by activating both peroxisome proliferation-activated receptor β/δ and retinoic acid receptor Mol. Cell. Biol. 29 2009 3286 3296
34. T. Kawada, Y. Kamei, A. Fujita, Y. Hida, E. Sugimoto, and T. Fushiki Carotenoids and retinoids as suppressors on adipocyte differentiation via nuclear receptors BioFactors 13 2000 103 109
35. O. Ziouzenkova, G. Orasanu, M. Sharlach, T.E. Akiyama, J.B. Berger, J. Viereck, J.A. Hamilton, G. Tang, G.G. Dolnikowski, S. Vogel, G. Duester, and J. Plutzky Retinaldehyde represses adipogenesis and diet-induced obesity Nat. Med. 13 2007 695 702
36. A. Molotkov, and G. Duester Genetic evidence that retinaldehyde dehydrogenase Raldh1 (Aldh1a1) functions downstream of alcohol dehydrogenase Adh1 in metabolism of retinol to retinoic acid J. Biol. Chem. 278 2003 36085 36090
37. J.J. Repa, K.K. Hanson, and M. Clagett-Dame All-trans-retinol is a ligand for the retinoic acid receptors Proc. Natl. Acad. Sci. U. S. A. 90 1993 7293 7297
38. O. Ziouzenkova, and J. Plutzky Retinoid metabolism and nuclear receptor responses: new insights into coordinated regulation of the PPAR-RXR complex FEBS Lett. 582 2008 32 38
39. X.D. Wang, G.W. Tang, J.G. Fox, N.I. Krinsky, and R.M. Russell Enzymatic conversion of β-carotene into β-apo-carotenals and retinoids by human, monkey, ferret, and rat tissues Arch. Biochem. Biophys. 285 1991 8 16
40. A. Eroglu, D.P. Hruszkewycz, R.W. Curley Jr., and E.H. Harrison The eccentric cleavage product of β-carotene, β-apo-13-carotenone, functions as an antagonist of RXRα Arch. Biochem. Biophys. 504 2010 11 16
41. K. Nagao, and T. Yanagita Bioactive lipids in metabolic syndrome Prog. Lipid Res. 47 2008 127 146
42. T. Sakuta, T. Uchiyama, and T. Kanayama Topical ER36009, a RARγ selective retinoid, decreases abdominal white adipose tissue and elicits changes in expression of genes related to adiposity and thermogenesis Endocrine 30 2006 113 119
43. I.G. Schulman, G. Shao, and R.A. Heyman Transactivation by retinoid X receptor-peroxisome proliferator-activated receptor γ (PPARγ) heterodimers: intermolecular synergy requires only the PPARγ hormone-dependent activation function Mol. Cell. Biol. 18 1998 3483 3494
44. V.R. Agarwal, E.D. Bischoff, T. Hermann, and W.W. Lamph Induction of adipocyte-specific gene expression as correlated with mammary tumor regression by the retinoid X receptor-ligand LGD1069 (Targretin) Cancer Res. 60 2000 6033 6038
45. P. Tontonoz, S. Singer, B.M. Forman, P. Sarraf, J.A. Fletcher, C.D.M. Fletcher, R.P. Brun, E. Mueller, S. Altiok, H. Oppenheim, R.M. Evans, and B.M. Spiegelman Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptor Proc. Natl. Acad. Sci. U. S. A. 94 1997 237 241
46. J.A. Pinaire, and A. Reifel-Miller Therapeutic potential of retinoid X receptor modulators for the treatment of the metabolic syndrome PPAR Res. 2007 2007 94156 10.1155/2007/94156
47. A.I. Shulman, and D.J. Mangelsdorf Retinoid X receptor heterodimers in the metabolic syndrome N. Engl. J. Med. 353 2005 604 615
48. L. Altucci, M.D. Leibowitz, K.M. Ogilvie, A.R. de Lera, and H. Gronemeyer RAR and RXR modulation in cancer and metabolic disease Nat. Rev. Drug Discovery 6 2007 793 810
49. L.G. Hamann An efficient, stereospecific synthesis of the dimmer-selective retinoid X receptor modulator (2E, 4E, 6Z)-7-[5, 6, 7, 8]-tetrahydro-5, 5, 8, 8-tetramethyl-2-(n-propyloxy)naphthalen-3-yl]-3- methylocta-2, 4, 6-trienoic acid J. Org. Chem. 65 2000 3233 3235
50. R.M. Cesario, K. Klausing, H. Razzaghi, D. Crombie, D. Rungta, R.A. Heyman, and D.S. Lala The rexinoid LG100754 is a novel RXR:PPARγ agonist and decreases glucose levels in vivo Mol. Endocrinol. 15 2001 1360 1369
51. P.Y. Michellys, R.J. Ardecky, J.H. Chen, D.L. Crombie, G.J. Etgen, M.M. Faul, A.L. Faulkner, T.S. Grese, R.A. Heyman, D.S. Karanewsky, K. Klausing, M.D. Leibowitz, S. Liu, D.A. Mais, C.M. Mapes, K.B. Marschke, A. Reifel-Miller, K.M. Ogilvie, D. Rungta, A.W. Thompson, J.S. Tyhonas, and M.F. Boehm Novel (2E, 4E, 6Z)-7-(2-alkoxy-3, 5-dialkylbenzene)-3-methylocta-2, 4, 6-trienoic acid retinoid X receptor modulators are active in models of type 2 diabetes J. Med. Chem. 46 2003 2683 2696
52. M.D. Leibowitz, R.J. Ardecky, M.F. Boehm, C.L. Broderick, M.A. Carfagna, D.L. Crombie, J. D'Arrigo, G.T. Etgen, M.M. Faul, T.A. Grese, H. Havel, N.I. Hein, R.A. Heyman, D. Jolley, K. Klausing, S. Liu, D.E. Mais, C.M. Mapes, K.B. Marschke, P.-Y. Michellys, C. Montrose-Rafizadeh, K.M. Olgivie, B. Pascual, D. Rungta, J.S. Tyhonas, M.S. Urcan, M. Wardlow, N. Yumibe, and A. Reifel-Miller Biological characterization of a heterodimer-selective retinoid X receptor modulator: potential benefits for the treatment of type 2 diabetes Endocrinology 147 2006 1044 1053
53. B.R. Haugen, D.R. Jensen, V. Sharma, L.K. Pulawa, W.R. Hays, W. Krezel, P. Chambon, and R.H. Eckel Retinoid X receptor γ-deficient mice have increased skeletal muscle lipoprotein lipase activity and less weight gain when fed a high-fat diet Endocrinology 145 2004 3679 3685
54. T. Yotsumoto, T. Naitoh, T. Kanaki, and N. Tsuruzoe A retinoid X receptor antagonist, HX531, improves leptin resistance without increasing plasma leptin levels in KK-Ay mice under normal dietary conditions Metab Clin. Exp. 54 2005 573 578
55. E.P. Santin, P. Germain, F. Quillard, H. Khanwalkar, F. Rodriguez-Barrios, H. Gronemeyer, A.R. de Lera, and W. Bourguet Modulating retinoid X receptor with a series of (E)-3-[4-hydroxy-3-(3-alkoxy-5, 5, 8, 8-tetramethyl-5, 6, 7, 8-tetrahydronaphthalen-2-yl)phenyl]acrylic acids and their 4-alkoxy isomers J. Med. Chem. 52 2009 3150 3158
56. B. Lagu, R. Lebedev, B. Pio, M. Yang, and P.D. Pelton Dihydro-[1H]-quinolin-2-ones as retinoid X receptor (RXR) agonists for potential treatment of dyslipidemia Bioorg. Med. Chem. Lett. 17 2007 3491 3496
57. J. Sakaki, M. Kishida, K. Konishi, H. Gunji, A. Toyao, Y. Matsumoto, T. Kanazawa, H. Uchiyama, H. Fukaya, H. Mitani, Y. Arai, and M. Kimura Synthesis and structure-activity relationship of novel RXR antagonists: orally active anti-diabetic and anti-obesity agents Bioorg. Med. Chem. Lett. 17 2007 4804 4807
58. K. Morishita, N. Yakushiji, F. Ohsawa, K. Takamatsu, N. Matsuura, M. Makishima, M. Kawahata, K. Yamaguchi, A. Tai, K. Sasaki, and H. Kakuta Replacing alkyl sulfonamide with aromatic sulfonamide in sulfonamide-type RXR agonists favors switch towards antagonist activity Bioorg. Med. Chem. Lett. 19 2009 1001 1003
59. S. Fujii, F. Ohsawa, S. Yamada, R. Shinozaki, R. Fukai, M. Makishima, S. Enomoto, A. Tai, and H. Kakuta Modification at the acidic domain of RXR agonists has little effect on permissive RXR-heterodimer activation Bioorg. Med. Chem. Lett. 20 2010 5139 5142
60. F. Ohsawa, K. Morishita, S. Yamada, M. Makishima, and H. Kakuta Modification at the lipophilic domain of RXR agonists differentially influences activation of RXR heterodimers ACS Med. Chem. Lett. 1 2010 521 525
61. S. Yamada, F. Ohsawa, S. Fujii, R. Shinozaki, M. Makashima, H. Naitou, S. Enomoto, A. Tai, and H. Kakuta Fluorescent retinoid X receptor ligands for fluorescence polarization assay Bioorg. Med. Chem. Lett. 20 2010 5143 5146
62. H. Kagechika, E. Kawachi, Y. Hashimoto, T. Himi, and K. Shudo Retinobenzoic acids. 1. Structure-activity relationships of aromatic amides with retinoidal activity J. Med. Chem. 31 1988 2182 2192
63. I. Miwako, and K. Shudo Oral administration of synthetic retinoid Am80 inhibits the development of type 1 diabetes in non-obese diabetic (NOD) mice Biol. Pharm. Bull. 32 2009 157 159
64. J.S. Chapman, K.L. Weiss, R.W. Curley Jr., M.A. Highland, and M. Clagett-Dame Hydrolysis of 4-HPR to atRA occurs in vivo but is not required for retinamide-induced apoptosis Arch. Biochem. Biophys. 419 2003 234 243
65. A.L. Anding, J.S. Chapman, D.W. Barnett, R.W. Curley Jr., and M. Clagett-Dame The unhydrolyzable fenretinide analogue 4-hydroxybenzylretinone induces the proapoptotic genes GADD153 (CHOP) and Bcl-2-binding component 3 (PUMA) and apoptosis that is caspase-dependent and independent of the retinoic acid receptor Cancer Res. 67 2007 6270 6277
66. M.F. Kenel, J.H. Krayer, E.A. Merz, and J.F. Pritchard Teratogenicity of N-(4-hydroxyphenyl)-all-trans-retinamide in rats and rabbits Teratog. Carcinog. Mutagen. 8 1988 1 11
67. R. Berni, and F. Formelli In vitro interaction of fenretinide with plasma retinol-binding protein and its functional consequences FEBS Lett. 308 1992 43 45
68. Q. Yang, T.E. Graham, N. Mody, F. Preitner, O.D. Peroni, J.M. Zabolotny, K. Kotani, L. Quadro, and B.B. Kahn Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes Nature 436 2005 356 362
69. F. Preitner, N. Mody, T.E. Graham, O.D. Peroni, and B.B. Kahn Long-term Fenretinide treatment prevents high-fat diet-induced obesity, insulin resistance, and hepatic steatosis Am. J. Physiol. Endocrinol. Metab. 297 2009 E1420 E1429
70. D.L. Newton, W.R. Henderson, and M.B. Sporn Structure-activity relationships of retinoids in hamster tracheal organ culture Cancer Res. 40 1980 3413 3425
71. Y.F. Shealy, J.L. Frye, C.A. O'Dell, M.C. Thorpe, M.C. Kirk, W.C. Coburn Jr., and M.B. Sporn Synthesis and properties of some 13-cis- and all-trans-retinamides J. Pharm. Sci. 73 1984 745 751
72. G.B. Villeneuve, and T.H. Chan A rapid, mild and acid-free procedure for the preparation of acyl chlorides including formyl chloride Tetrahedron Lett. 38 1997 6489 6492
73. S.M. Mershon, A.L. Anding, J.S. Chapman, M. Clagett-Dame, L.A. Stonerock, and R.W. Curley Jr. Solid phase-assisted synthesis and screening of a small library of N-(4-hydroxyphenyl)retinamide (4-HPR) analogs Bioorg. Med. Chem. Lett. 17 2007 836 840
74. A. Jetten Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism Nucl. Recept. Signal. 7 2009 e003 10.1621/nrs.07003
75. L.A. Solt, P.R. Griffin, and T.P. Burris Ligand regulation of retinoic acid receptor-related orphan receptors: implications for development of novel therapeutics Curr. Opin. Lipidol. 21 2010 204 211
76. S.K. Natarajan, S. Thomas, A. Ramachandran, A.B. Pulimood, and K.A. Balsubramanian Retinoid metabolism during development of liver cirrhosis Arch. Biochem. Biophys. 443 2005 93 100
77. A.A. Ashia, Y. Hoshikawa, H. Tsuchiya, K. Hashiguchi, M. Enjoji, M. Nakamuta, A. Taketomi, Y. Maehara, K. Shomori, A. Kurimasa, I. Hisatome, H. Ito, and G. Shiota Genetic analysis of expression profile involved in retinoid metabolism in non-alcoholic fatty liver disease Hepatol. Res. 40 2010 594 604
78. M.A. Gyamfi, M.G. Kocsis, L. He, G. Dai, A.J. Mendy, and Y.-J.Y. Wan The role of retinoid X receptor α in regulating alcohol metabolism J. Pharmacol. Exp. Ther. 319 2006 360 368
79. T. Mello, S. Polvani, and A. Galli Peroxisome proliferator-activated receptor and retinoic X receptor in alcoholic liver disease PPAR Res. 2009 2009 748174 10.1155/2009/748174
80. Q. Xu, J. Lucio-Cazana, M. Kitamura, X. Ruan, L.G. Fine, and J.T. Norman Retinoids in nephrology: promises and pitfalls Kidney Int. 66 2004 2119 2131
81. S.-Y. Han, G. So, Y.-H. Jee, K.-H. Han, Y.-S. Kang, H.-K. Kim, S.-W. Kang, D.-S. Han, J.-Y. Han, and D.-R. Cha Effect of retinoic acid in experimental diabetic nephropathy Immunol. Cell Biol. 82 2004 568 576
82. M.R. Davies, L.R. Ribeiro, M. Downey-Jones, M.R.C. Needham, C. Oakley, and J. Wardale Ligands for retinoid acid receptors are elevated in osteoarthritis and may contribute to pathologic processes in the osteoarthritic joint Arthritis Rheum. 60 2009 1722 1732